Anticoagulation following tissue aortic valve replacement
Not Applicable
Completed
- Conditions
- Aortic valve diseaseCirculatory System
- Registration Number
- ISRCTN51663857
- Lead Sponsor
- St George's Healthcare NHS Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Patients undergoing tissue aortic valve replacement
Exclusion Criteria
1. Patients who require aspirin or warfarin therapy on established medical grounds
2. Patients unable to take warfarin or aspirin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method